Tortoise Investment Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-312
| Closed | -$9.95K | – | 805 |
|
2023
Q3 | $9.95K | Hold |
312
| – | – | ﹤0.01% | 556 |
|
2023
Q2 | $12.5K | Hold |
312
| – | – | ﹤0.01% | 524 |
|
2023
Q1 | $13.3K | Hold |
312
| – | – | ﹤0.01% | 511 |
|
2022
Q4 | $15K | Hold |
312
| – | – | ﹤0.01% | 493 |
|
2022
Q3 | $12K | Hold |
312
| – | – | ﹤0.01% | 499 |
|
2022
Q2 | $9K | Hold |
312
| – | – | ﹤0.01% | 525 |
|
2022
Q1 | $17K | Hold |
312
| – | – | ﹤0.01% | 442 |
|
2021
Q4 | $18K | Hold |
312
| – | – | ﹤0.01% | 417 |
|
2021
Q3 | $12K | Hold |
312
| – | – | ﹤0.01% | 447 |
|
2021
Q2 | $13K | Buy |
312
+219
| +235% | +$9.13K | ﹤0.01% | 431 |
|
2021
Q1 | $6K | Buy |
+93
| New | +$6K | ﹤0.01% | 480 |
|